Thomas F. Gajewski
Geen lopende functies
Profiel
Thomas F.
Gajewski is the founder of Jounce Therapeutics, Inc. (founded in 2013).
Dr. Gajewski is also the founder of Pyxis Oncology, Inc. He received his undergraduate and doctorate degrees from The University of Chicago.
Eerdere bekende functies van Thomas F. Gajewski
| Bedrijven | Functie | Einde |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Oprichter | - |
| JOUNCE THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Thomas F. Gajewski
| The University of Chicago | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |